Your browser doesn't support javascript.
loading
Efficacy and Safety of Tofacitinib in Ulcerative Colitis Based on Prior Tumor Necrosis Factor Inhibitor Failure Status.
Sandborn, William J; Peyrin-Biroulet, Laurent; Sharara, Ala I; Su, Chinyu; Modesto, Irene; Mundayat, Rajiv; Gunay, L Mert; Salese, Leonardo; Sands, Bruce E.
Afiliação
  • Sandborn WJ; Division of Gastroenterology, University of California San Diego, La Jolla, California. Electronic address: wsandborn@health.ucsd.edu.
  • Peyrin-Biroulet L; Inserm Nutrition, Genetics, and Environmental Risk Exposure U1256, Department of Gastroenterology, Nancy University Hospital, Lorraine University, Vandœuvre lès-Nancy, France.
  • Sharara AI; Division of Gastroenterology, American University of Beirut Medical Center, Beirut, Lebanon.
  • Su C; Pfizer Inc, Collegeville, Pennsylvania.
  • Modesto I; Pfizer Inc, New York, New York.
  • Mundayat R; Pfizer Inc, New York, New York.
  • Gunay LM; Pfizer Inc, Istanbul, Turkey.
  • Salese L; Pfizer Inc, Collegeville, Pennsylvania.
  • Sands BE; Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York.
Clin Gastroenterol Hepatol ; 20(3): 591-601.e8, 2022 03.
Article em En | MEDLINE | ID: mdl-33684552

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Colite Ulcerativa / Inibidores do Fator de Necrose Tumoral Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Clin Gastroenterol Hepatol Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Colite Ulcerativa / Inibidores do Fator de Necrose Tumoral Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Clin Gastroenterol Hepatol Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2022 Tipo de documento: Article